US FDA explains how to use patient-reported outcomes to support labelling claims
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued final guidance explaining how it evaluates patient-reported outcomes to measure treatment benefit in medical product clinical trials1,2.